Market Overview

HeartWare Sees Q4 Sales ~$32M

Related HTWR
Keep An Eye On This New Activist Hedge Fund Managed By Former JPMorgan Executives
HeartWare Terminates Proposed Acquisition of Valtech Cardio

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects total revenues for the fourth quarter of 2012 will be approximately $32 million, bringing expected full-year 2012 revenues to approximately $110 million.

Posted-In: News Guidance


Related Articles (HTWR)

Get Benzinga's Newsletters